Gilead, Merck weekly HIV pill keeps virus suppressed in late-stage trials - Reuters
Gilead, Merck weekly HIV pill keeps virus suppressed in late-stage trials Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxOc2tTZEstZ2FTWXFuRk5lU1BGbXNKSWxfNExEWkM0NHgwWEFXWW45SGtsZTRsT0RqaGdaOUdGbXRCbWZkV3lQZU0xTXJsa0NOcmxwY3lIbnE3a2liNThINU1YbW9zb1hhMnVWTVo5VzVJZ2w1bVI3YVloaURuOTZ5bDkwWDdkN1o3TF9HemRJTjNOYXZTczJBQy1PMzFHQU1meXJ1UTY5MGtWXzh1QktZV1RBLWtobzF4amVzUFN0cw?oc=5" target="_blank">Gilead, Merck weekly HIV pill keeps virus suppressed in late-stage trials</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Lawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMModerna shares surge as melanoma vaccine with Merck succeeds in large trial - reuters.com
Moderna shares surge as melanoma vaccine with Merck succeeds in large trial reuters.com
August 19, 2026 at 12:17 PMEyePoint's drug for age-related eye disease fails late-stage trial, shares tank - Reuters
EyePoint's drug for age-related eye disease fails late-stage trial, shares tank Reuters
August 17, 2026 at 03:45 PMVIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results - Reuters
VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results Reuters
August 19, 2026 at 02:45 PMModerna, Merck breakthrough could usher in wave of cancer vaccines - Reuters
Moderna, Merck breakthrough could usher in wave of cancer vaccines Reuters
August 19, 2026 at 09:01 PMNovo begins study to find lowest effective dose for Wegovy pill - Reuters
Novo begins study to find lowest effective dose for Wegovy pill Reuters
August 19, 2026 at 03:26 PM